latest news releases from the newsroom
Centale, Inc. Adds Eight More to Its Network Affiliate Group
EAST AURORA, N.Y., Feb. 15, 2007 (PRIME NEWSWIRE) -- Centale, Inc. (OTCBB:CNTL) is pleased to announce the addition of eight more to its Network Affiliate Group as part of its new marketing plan. The new Affiliates represent business networks from a wide variety of industries including Entertainment, Real Estate, Financial Services and Technology.
Alagebrium Demonstrates Cardiovascular Activity in Recently Published Report Indicating Potential Wide-Ranging Benefits in Cardiovascular Diseases
PARSIPPANY, N.J., February 15, 2007 (PRIME NEWSWIRE) -- Alteon Inc. (AMEX:ALT) announced today that data demonstrating the ability of its compound, alagebrium, to augment flow-mediated dilation (FMD) is the subject of a paper published in the March 2007, Volume 25, No. 3 issue of the Journal of Hypertension, by Susan Zieman, M.D, Ph.D., Assistant Professor, Department of Medicine (Cardiology), and colleagues from Johns Hopkins School of Medicine. The paper, describing an investigator-sponsored Phase 2 clinical trial, indicates that alagebrium can induce changes in flow-mediated dilation and a variety of biomarkers related to inflammation, matrix turnover and endothelial function. The Company believes that this pragmatic demonstration of alagebrium's biological activity in human clinical subjects using a collection of well-validated biomarkers, is supportive of the Company's plans to advance alagebrium's development in cardiac and vascular mediated disease.